Annual Total Liabilities
$99.12 M
+$95.74 M+2829.11%
December 31, 2023
Summary
- As of February 8, 2025, ALRN annual total liabilities is $99.12 million, with the most recent change of +$95.74 million (+2829.11%) on December 31, 2023.
- During the last 3 years, ALRN annual total liabilities has risen by +$94.94 million (+2271.88%).
- ALRN annual total liabilities is now -25.93% below its all-time high of $133.83 million, reached on December 31, 2016.
Performance
ALRN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$53.99 M
+$606.00 K+1.14%
September 30, 2024
Summary
- As of February 8, 2025, ALRN quarterly total liabilities is $53.99 million, with the most recent change of +$606.00 thousand (+1.14%) on September 30, 2024.
- Over the past year, ALRN quarterly total liabilities has increased by +$52.37 million (+3224.51%).
- ALRN quarterly total liabilities is now -60.27% below its all-time high of $135.88 million, reached on June 30, 2017.
Performance
ALRN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALRN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2829.1% | +3224.5% |
| 3 y3 years | +2271.9% | +1495.5% |
| 5 y5 years | +825.3% | +1495.5% |
ALRN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2829.1% | -45.5% | +4410.4% |
| 5 y | 5-year | at high | +2829.1% | -45.5% | +4410.4% |
| alltime | all time | -25.9% | +2829.1% | -60.3% | +4410.4% |
Aileron Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $53.99 M(+1.1%) |
| Jun 2024 | - | $53.38 M(-1.9%) |
| Mar 2024 | - | $54.44 M(-45.1%) |
| Dec 2023 | $99.12 M(+2829.1%) | $99.12 M(+6003.5%) |
| Sep 2023 | - | $1.62 M(+35.7%) |
| Jun 2023 | - | $1.20 M(-58.5%) |
| Mar 2023 | - | $2.88 M(-14.8%) |
| Dec 2022 | $3.38 M(-26.1%) | $3.38 M(-25.4%) |
| Sep 2022 | - | $4.54 M(-11.9%) |
| Jun 2022 | - | $5.15 M(+24.2%) |
| Mar 2022 | - | $4.15 M(-9.4%) |
| Dec 2021 | $4.58 M(+9.5%) | $4.58 M(-1.8%) |
| Sep 2021 | - | $4.66 M(+5.9%) |
| Jun 2021 | - | $4.40 M(+35.3%) |
| Mar 2021 | - | $3.25 M(-22.2%) |
| Dec 2020 | $4.18 M | $4.18 M(-57.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $9.78 M(+3.3%) |
| Jun 2020 | - | $9.47 M(-10.7%) |
| Mar 2020 | - | $10.60 M(+1.7%) |
| Dec 2019 | $10.43 M(-2.7%) | $10.43 M(-6.4%) |
| Sep 2019 | - | $11.14 M(+9.1%) |
| Jun 2019 | - | $10.21 M(+6.9%) |
| Mar 2019 | - | $9.55 M(-10.8%) |
| Dec 2018 | $10.71 M(+119.0%) | $10.71 M(-11.5%) |
| Sep 2018 | - | $12.10 M(+24.6%) |
| Jun 2018 | - | $9.71 M(+99.9%) |
| Mar 2018 | - | $4.86 M(-0.7%) |
| Dec 2017 | $4.89 M(-96.3%) | $4.89 M(-2.6%) |
| Sep 2017 | - | $5.02 M(-96.3%) |
| Jun 2017 | - | $135.88 M(+4626.4%) |
| Mar 2017 | - | $2.88 M(-97.9%) |
| Dec 2016 | $133.83 M(+33.5%) | $133.83 M |
| Dec 2015 | $100.26 M | - |
FAQ
- What is Aileron Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aileron Therapeutics?
- What is Aileron Therapeutics annual total liabilities year-on-year change?
- What is Aileron Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly total liabilities year-on-year change?
What is Aileron Therapeutics annual total liabilities?
The current annual total liabilities of ALRN is $99.12 M
What is the all time high annual total liabilities for Aileron Therapeutics?
Aileron Therapeutics all-time high annual total liabilities is $133.83 M
What is Aileron Therapeutics annual total liabilities year-on-year change?
Over the past year, ALRN annual total liabilities has changed by +$95.74 M (+2829.11%)
What is Aileron Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ALRN is $53.99 M
What is the all time high quarterly total liabilities for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly total liabilities is $135.88 M
What is Aileron Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ALRN quarterly total liabilities has changed by +$52.37 M (+3224.51%)